Verix Health, founded by Professor Mark Yim, PhD, in collaboration with PCI Ventures at the University of Pennsylvania, is pioneering a suite of actively steerable surgical devices. Their core mission is to enable minimally invasive diagnosis and treatment of lesions in hard-to-reach anatomical areas. Incubated at the Pennovation Center in Philadelphia, Verix Health focuses on providing innovative solutions for interventional oncologists, aiming to improve patient outcomes through advanced technology.
Notable affiliations include the University of Pennsylvania and PCI Ventures. Verix Health has achieved significant milestones in developing its platform of surgical devices, which are designed to enhance precision and control during cancer treatments. The company's impact lies in its potential to revolutionize minimally invasive surgeries, offering new hope for patients with difficult-to-access tumors and advancing the field of interventional oncology.
